While most people are familiar with Alzheimer’s disease, a progressive neurological disorder and the most common cause of dementia, it is often difficult to truly understand the common symptoms and ...

Agitation is a neuropsychiatric symptom in patients with Alzheimer's disease (AD), the most common form of dementia. The prevalence of this symptom is about 40%-65% ...

Please provide your email address to receive an email when new articles are posted on . Researchers reviewed 18 randomized clinical trials that recruited individuals with dementia and ...

WASHINGTON, Nov. 12, 2025 /PRNewswire/ -- Nearly half (49%) of those caring for someone experiencing agitation symptoms as part of their Alzheimer's dementia reveal that the agitation symptoms are ...

Alzheimer’s disease is the most commonly diagnosed form of dementia, but it’s far from the only one. In fact, most people who ...

Brexpiprazole (Rexulti) is effective for treating agitation associated with Alzheimer's dementia (AAD), but appears to carry the increased risk for death observed with other antipsychotics in elderly ...

Please provide your email address to receive an email when new articles are posted on . The model, along with a traffic-light system, boosted sensitivity and specificity of agitation recognition.

Approximately 6.5 million Americans and their loved ones, friends, and caregivers experience the distress associated with Alzheimer’s dementia. One of the most troubling symptoms associated with this ...

Credit: Getty Images. Brexpiprazole is an atypical antipsychotic. The Food and Drug Administration (FDA) has approved Rexulti ® (brexpiprazole) for the treatment of agitation associated with dementia ...

In a recent study published in the Journal of the American Geriatrics Society, a group of researchers assessed the longitudinal relationship between chronic, resolved, and new onset anxiety and the ...